Loading...
NPI 1538692876 · Westmont, IL · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Chicago Vascular Asc LLC is a ambulatory surgical clinic/center provider located in Westmont, Illinois. This profile covers 20 Medicare and 1 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Chicago Vascular Asc LLC |
| Address | 700 Pasquinelli Dr |
| City | Westmont |
| State | IL |
| ZIP | 60559 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | April 4, 2017 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $6M |
| Medicaid | $0 |
CHICAGO VASCULAR ASC LLC is functionally a dialysis-access interventional ambulatory surgical center: its top Medicare codes (36902, 36903, C7513) are all diagnostic and therapeutic dialysis-circuit angiography/angioplasty and stent procedures, indicating the practice is centered on endovascular treatment of dialysis access rather than general ambulatory surgery. The provider taxonomy is Ambulatory Surgical Clinic/Center and the code mix—high volumes of transluminal balloon angioplasty, stent placement, and dialysis-circuit angiography—supports a specialized vascular access service line.
Revenue is highly concentrated in a small set of dialysis-access interventions: the precomputed top-3 codes account for 76.0% of this provider's total Medicare revenue, with 36902 alone representing $3.1M (51.3% of Medicare revenue). This concentration implies that a few high-acuity interventional services are the primary drivers of the business.
The provider is effectively single-payer at scale: lifetime Medicare revenue is $6M while lifetime Medicaid revenue is $0, so Medicaid does not materially contribute to this facility’s billed volume or revenue. Analysts should treat Medicare as the dominant commercial exposure and not expect inpatient/state Medicaid billing patterns to inform this ASC’s core business.
CHICAGO VASCULAR ASC demonstrates national-level dominance on several key interventional dialysis codes: 36902 ranks #1 of 1666 providers nationally (100th percentile) and is described as an extreme outlier, C7513 ranks #1 of 65 providers nationally (100th percentile) and is also an extreme outlier, and 36903 ranks #4 of 289 providers nationally (99th percentile) and is likewise an extreme outlier. These rank/percentile positions indicate volumes for these specific services that are far above typical national peers and consistent with a regional referral hub for dialysis-access interventions.
Beyond the top three, the provider shows above-typical volumes on additional complex interventional codes: 36906 ($549.2K, 9.1% of Medicare revenue) ranks #7 of 155 (96th percentile; notably above typical national volume) and 36905 ($392.5K, 6.5% of Medicare revenue) ranks #19 of 396 (95th percentile; notably above typical national volume). This pattern—multiple high-percentile placements on thrombectomy and combined thrombectomy/angioplasty-stent codes—supports the conclusion that the ASC routinely manages complex dialysis-access occlusion and clot cases.
Several ancillary and lower-revenue codes appear at modest to typical volumes, reflecting the broader procedural mix needed to support dialysis-access care: examples include 36581 ($86.9K, 1.4% of Medicare revenue) ranking #31 of 462 (93th percentile) and J2997 (alteplase) with 238 claims generating $16.4K (0.3% of Medicare revenue) and ranking #13 of 199 (94th percentile). These secondary codes are consistent with the clinical requirements of thrombectomy and thrombolysis adjuncts but do not materially shift the overall revenue concentration.
The provider’s NPI tenure is long enough to suggest an established operation: NPI enumerated 2017-04-04 (~9 years ago). Given sustained, high-volume billing on specialized dialysis-access codes over that period, this appears to be a stable, specialty-focused ASC rather than a newly pivoted practice.
From a competitive and contracting viewpoint, payers should note the facility’s outsized role in a narrow set of high-reimbursement, high-complexity dialysis-access procedures—36902 averages $1839 paid/claim, 36903 averages $5430 paid/claim, and 36906 averages $9003 paid/claim—so network adequacy and rate negotiations for dialysis-access interventions at this ASC could materially affect local beneficiary access to these procedures. The combination of concentrated revenue, national top ranks, and zero Medicaid revenue frames this provider as a Medicare-centric specialty center with leverage on dialysis-access services.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
20 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36902 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects contrast material into the dialysis access point to visualize… | 1,680 | $1,840 | $3.1M |
| 36903 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects contrast material into the dialysis access point to visualize… | 160 | $5,430 | $890.5K |
| C7513 | Dialysis circuit, introduction of needle(s) and/or catheter(s), with diagnostic angiography of the dialysis circuit, including all direct puncture(s) and catheter placement(s), injection(s) of… | 660 | $900 | $596.9K |
| 36906 | Under fluoroscopic guidance (live X–rays which can be viewed on a monitor), the provider introduces a catheter into a vessel in the dialysis circuit and extracts a blood clot (hematoma) with special… | 60 | $9,000 | $549.2K |
| 36905 | Under fluoroscopic guidance (live X–rays that can be viewed on a monitor), the provider introduces a catheter into a vessel in the dialysis circuit and extracts a blood clot (hematoma) with special… | 90 | $4,620 | $392.5K |
| 36581 | This procedure is a complete replacement of a tunneled CVA catheter in cases of blockage, damage, or malfunction. | 70 | $1,260 | $86.9K |
| 37187 | In this procedure, the provider treats an occlusion, or blockage, in a vein by using a combined technique of mechanical thrombectomy and pharmacological thrombolytic injection. He also uses… | 10 | $5,850 | $81.9K |
| 37246 | Using an open incision or a percutaneous (small incision in the skin) approach, the provider places a balloon–tipped catheter into the lumen (interior) of an artery. He expands the balloon as many… | 40 | $2,290 | $80K |
| C7532 | Transluminal balloon angioplasty (except lower extremity artery(ies) for occlusive disease, intracranial, coronary, pulmonary, or dialysis circuit), initial artery, open or percutaneous, including… | 20 | $4,220 | $75.9K |
| 36901 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects intravenous contrast material to visualize and record images of… | 70 | $400 | $28.1K |
Showing 1–10 of 20
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 20 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
20 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| C7513 | 1 | 10 | 350 | $910 | $314.8K |
| 36906 | 2 | 10 | 30 | $4,860 | $165.3K |
| 36903 | 1 | 10 | 20 | $2,830 | $101.9K |
| 36902 | 1 | 80 | 40 | $910 | $84.5K |
| 37187 | 1 | 10 | 10 | $5,850 | $81.9K |
| C7532 | 1 | 10 | 20 | $4,220 | $75.9K |
| 36905 | 1 | 20 | 20 | $2,450 | $63.7K |
| 36478 | 24 | 40 | 30 | $770 | $33.7K |
| 37246 | 1 | 10 | 20 | $1,080 | $23.8K |
| 37248 | 5 | 10 | 10 | $1,000 | $19.9K |
Showing 1–10 of 20
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
1 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 36902 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects contrast material into the dialysis access point to visualize… | 1,040 | $0 | $0 |
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
1 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 36902 | The provider introduces a needle and/or catheter under fluoroscopic guidance (live X–rays that can be viewed on a monitor) and injects contrast material into the dialysis access point to visualize… | 3 | 20 | 40 | $30 | $9.2K |
Other providers in the same ZIP code as Chicago Vascular Asc LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.